secwatch.observer — SEC 8-K summary
======================================

Issuer:     Protagonist Therapeutics, Inc (PTGX)
CIK:        0001377121
Form:       8-K
Filed at:   2022-06-02T23:59:59+00:00
Accession:  0001104659-22-067589
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Protagonist Therapeutics stockholder meeting approves director elections, say-on-pay, and auditor ratification
--------------------------------------------------------------------------------

- Harold Selick and Bryan Giraudo elected Class III directors with 27.9M and 28.1M votes for, respectively.
- Advisory say-on-pay approved: 35.8M for, 0.4M against; 2.4M broker non-votes.
- Non-binding vote favored annual say-on-pay frequency (35.6M for 1 year); company intends annual votes.
- Ernst & Young ratified as auditor for FY2022: 38.7M for, 5.6K against, 1.5K abstain.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1377121/000110465922067589/0001104659-22-067589-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1377121/000110465922067589/tm2217556d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-22-067589

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer